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ABSTRACT 
A stability-indicating high-performance thin-layer chromatographic (HPTLC)  method has been developed for the determination of 
simultaneous determination of Enalapril maleate (ENAL), Hydrochlorothiazide (HCTZ) and Paracetamol (PARA)  in tablet dosage 
forms, The separation was achieved on TLC aluminum plates precoated with silica gel 60F-254 using chloroform: methanol: toluene 
: ethyl acetate (20:10:40:30 % v/v/v/v)  as the mobile phase. The densitometric analysis was carried out at 230 nm. Compact bands 
appeared at Rf 0.21 ± 0.01, 0.50 ± 0.02 and 0.73 ± 0.01 respectively, for ENAL, HCTZ and PARA. Linear regression analysis 
revealed linearity in the range of 1000 – 6550 ng/spot for ENAL, 100-3600 ng/spot for HCTZ and 500 – 3400 ng/spot for PARA. 
Drugs were subjected to acid and alkali hydrolyses, forced oxidation, thermal and photo degradation treatments. The degraded 
products were well separated from the pure drugs. Statistical analysis proved that the method is precise, accurate, selective and 
economical and may be used for routine analysis of ENAL, HCTZ and PARA in tablet dosage forms.  
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Delivery and Therapeutics. 2017; 7(7):97-99 
 
INTRODUCTION: 
Enalapril Maleate is an angiotensin converting enzyme 
(ACE) inhibitor used in the treatment of hypertension 
and some types of chronic heart failure, 
hydrochlorthiazide, is a first line diuretic drug of the 
thiazide class that acts by inhibiting the kidneys’ ability 
to retain water, paracetamol are widely used as an 
analgesic.
1-5 
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EXPERIMENTAL: 
HPTLC method for simultaneous estimation of ENAL, 
HCTZ and PARA in combined tablet dosage form was 
developed using HPTLC (CAMAG (Muttenz, 
Switzerland). Chloroform: Methanol: Toluene: Ethyl 
acetate (20: 10: 40: 30 % v/v/v/v) was optimized as 
mobile phase. 
 Preparation of standard stock solution: Stock solution of 
each drug having concentration of 0.1 mg mL
-1
 (100 ng 
μL-1) was prepared separately in mobile phase.  
 Analysis of commercial formulation: The method was 
applied for the quantitative study of drugs in 
commercially available tablets. For the preparation of 
the stock solution of tablet dosage form, 20 tablet of 
INVOZIDE (Ranbaxy Laboratories Ltd, Dewas) were 
taken and their average weight was determined. 20 
tablets were crushed and weighed. Powder equivalent to 
5 mg of ENAL in 10 mL volumetric flask and dissolved 
in 5 mL of mobile phase with vigorous shaking for 5 
minutes.  The supernatant liquid was transferred to 10 
mL of volumetric flask through a whatman no. 41 filter 
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paper. Five replicates of sample solutions were prepared 
and applied. The concentrations of these drugs were 
extrapolated from their respective calibration curves by 
using the peak area of densitogram.  
RESULTS AND DISCUSSION: 
The HPTLC method was developed and validated 
according to ICH guidelines.
 [1]
 ENAL, HCTZ and 
PARA have shown good linear relationship for ENAL, 
HCTZ and PARA in the working concentration range 
(linearity range) of 1000 to 6550 ng per band, 100 to 
3600 ng per band and 500 to 3400 ng per band, 
respectively. Precision of the method was determined in 
terms of intra-day and inter-day variation (% RSD). The 
accuracy of the proposed method was evaluated by 
percentage recovery of all three drugs. (Fig. 1 shows the 
peaks, overlays and of ENAL, HCTZ and PARA at 215 
nm, 270 nm and 245 nm respectively).  
 
 
Figure 1: (a) Peaks (b) overlay of ENAL, HCTZ and PARA respectively 
 
Figure 2: HPTLC chromatogram obtained from acid degradation for (a) ENAL (b) HCTZ (c) PARA 
Table 1: Forced degradation study for ENAL, HCTZ and PARA 
Parameters  Sample Exposure Condition  No. of Degradation Products (Rf Values)  %  Recovery  
  
  
ENAL  
  
  
0.1 N HCl, 2 Hours, 60 ºC 1 (0.20) 61.52 ± 1.68 
0.01 N NaoH, 2 Hours, 60 ºC 3 ( 0.17, 0.33, 0.45 ) 69.28 ± 3.09 
13 % H2O2, 1 Hours, 60 ºC 3 ( 0.4, 0.78, 0.8 ) 81.69 ± 3.68 
Photo.chem, 8h 1 (0.32 ) 71.18 ± 2.70 
Dry Heat, 3h, 55 ºC 2 ( 0.34, 0.46 ) 73.35 ± 1.84 
  
  
HCTZ  
  
  
0.1 N HCl, 2 Hours, 60 ºC 3 ( 0.20, 0.42, 0.72 ) 81.11 ± 5.63 
0.01 N NaoH, 2 Hours, 60 ºC 3 ( 0.18, 0.45, 0.78 ) 63.87 ± 2.41 
13 % H2O2, 1 Hours, 60 ºC 4 ( 0.09, 0.15, 0.34, 0.71 ) 54.10 ± 3.26 
Photo.chem, 8h 2 ( 0.43, 0.72 ) 50.79±1.83 
Dry Heat, 3h, 55 ºC 3 ( 0.16, 0.23, 0.44) 61.42 ± 2.94 
  
 PARA 
  
0.1 N HCl, 2 Hours, 60 ºC 2 ( 0.37, 0.39 ) 72.80 ± 2.93 
0.01 N NaoH, 2 Hours, 60 ºC 1(0.85) 76.82 ± 2.93 
13 % H2O2, 1 Hours, 60 ºC 1(0.89) 62.65 ± 2.14 
Photo.chem, 8h 1 ( 0.31 ) 50.76 ± 2.49  
Dry Heat, 3h, 55 ºC 2 ( 0.33, 0.74 ) 61.99 ± 2.08 
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Table 2: Validation parameters of the HPTLC method 
Parameters  ENAL  HCTZ  PARA  
Linearity range 1000-6550  500-3400  100-3600  
Correl. coeff. (r
2
)  0.993 0.996 0.995 
Slope 2.8398 6.9042 5.079 
Intercept  396.89 17.837 971.97 
Recovery (%) 99.27 + 0.41  99.85 + 0.065  99.98 + 0.023  
Precision 
Intraday (n = 3) 3255.1 + 5.17  3505.33 +  62.51  3274.86 +  20.70  
Interday (n = 3)  3237.23 +  71.47  3477.533 + 21.0003  3284.367 + 4.743  
Repeatability 3345.65 + 12.08  5429.967 + 26.01  5077.4 +  6.371  
LOD 73.24 18.24 82.2 
LOQ 221.9 55.3 249.1 
Detection Wavelenth 215 nm 270 nm 245 nm 
Rf  Value 0.20 ± 0.04 0.55 ± 0.03 0.72 ± 0.02 
 
Table 3: Summary of Validation Parameters of HPTLC Method 
Particulars  Specifications  
Make  CAMAG , Switzerland  
Applicator  Camag Linomat 5, Semi automatic application, band application by spray on technique (2-
500mL).  
Syringe  Hamilton 100 ml HPTLC syringe.  
Stationary Phase  Silica Gel 60 G F254 coated on aluminium sheet. (Merck, Germany)  
Chamber  Camag twin trough glass chamber (10cm´10cm & 20cm´10cm).  
Scanner  Camag TLC Scanner 3, scan speed up to 100mm/s, Spectral range 190-800nm.  
Software  WinCATS Planner Chromatography Manager, version 1.3.4.  
Documentation  Camag Reprostar 3 with digital camera for 254 nm, 366 nm and visible light source.  
UV Cabinet  Camag UV cabinet with dual wavelength UV lamp 254 & 366 nm.  
Detection Wavelength  ENAL  - 215 nm 
HCTZ  - 270 nm 
PARA  - 245 nm  
Mobile Phase  
Chloroform : Methanol : Toluene : Ethyl acetate 
(20 : 10 : 40 : 30, v/v/v/v) 
Rf  Value  
ENAL  - 0.20 ± 0.04 
HCTZ - 0.55 ± 0.03 
PARA  - 0.72 ± 0.02 
 
The developed HPLC method is simple, precise, 
accurate and reproducible and can used for simultaneous 
determination of enalapril maleate, hydrochlorothiazide, 
paracetamol in tablets. The method was validated as per 
ICH guidelines.  
CONCLUSION: 
As a result, simple, rapid and economical method for the 
simultaneous analysis of multicomponent formulation, 
which doesn’t require extraction or separation of the 
analyte from themselves or from the excipients, 
becomes necessary for the pharmaceutical industry. By 
keeping all this in mind in the present study a new, 
simple, rapid, economic, accurate and selective, HPTLC 
method has been developed for simultaneous 
quantitative estimation of Enalapril maleate, 
Hydrochlorothiazide and Paracetamol in bulk and tablet 
dosage form. 
Mobile phase selected for analysis was Chloroform: 
Methanol: Toluene: Ethyl acetate (20: 10: 40: 30 % 
v/v/v/v). The retention values for ENAL, HCTZ and 
PARA were found to 0.2.0.55 and 0.72 respectively.  
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